The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|October 1, 1998
The American Journal of Managed Care
- October 1998
- Volume 4
- Issue 10
Determining the Cost of Gastroesophageal Reflux Disease: A Decision Analytic Model
Advertisement
Articles in this issue
about 28 years ago
Where Is the Financial Safety Net for Managed Care Physiciansabout 28 years ago
How Should Managed Care Treat Onychomycosis?Advertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5